1. Home
  2. AMST vs BMRA Comparison

AMST vs BMRA Comparison

Compare AMST & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

HOLD

Current Price

$0.83

Market Cap

8.2M

Sector

Technology

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.24

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMST
BMRA
Founded
2017
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
6.8M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
AMST
BMRA
Price
$0.83
$2.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
745.4K
13.2K
Earning Date
05-13-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
N/A
EPS
N/A
N/A
Revenue
$110,459.00
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$1.87
52 Week High
$4.78
$4.60

Technical Indicators

Market Signals
Indicator
AMST
BMRA
Relative Strength Index (RSI) 30.07 58.23
Support Level N/A $2.11
Resistance Level $2.07 $2.40
Average True Range (ATR) 0.27 0.05
MACD -0.03 0.00
Stochastic Oscillator 2.88 100.00

Price Performance

Historical Comparison
AMST
BMRA

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: